PositiveID

Biological Detection and Diagnostics

PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats for homeland defense, as well as analyze biological samples at the point of care.

Click here to view our products

Recent News

June 6, 2014
PositiveID Issues First-Ever Revenue Guidance of $4-10 Million Over Next 18 Months as Government Procurements for Bio-Threat Detection Increase
more
May 27, 2014
PositiveID Corporation Updates Stockholders on 2014 Progress
more
May 14, 2014
PositiveID Corporation to Present at the Third Annual Marcum MicroCap Conference
more
May 5, 2014
PositiveID Corporation Signs Space Act Agreement With NASA
more
April 24, 2014
PositiveID Corporation Teaming Partner Leidos Awarded Defense Threat Reduction Agency Contract Valued at Up to $4 Billion
more
View Archives

PositiveID Corporation™ (OTCQB: PSID)

PositiveID Corporation™ is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid medical testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.

M-BAND

PositiveID specializes in airborne pathogen detection, rapid clinical diagnostics and sample preparation applications. more

Company report

PositiveID and Secure Strategy Group have published a report on PositiveID. more

Firefly

PositiveID is developing a portable, handheld biological detection system. more

PositiveID™ Corporation, 2014 - All Rights Reserved